Moderna’s Super-Vaccine for Flu and Covid Works—Now Politics Could Sink It

Moderna’s innovative combination vaccine, mRNA-1083, has shown promising results in preventing both flu and COVID-19 infections with strong immune responses, making it a significant step toward pandemic preparedness. However, the Food and Drug Administration's recent policy requiring all vaccines to undergo placebo-controlled trials may delay or complicate approvals, particularly for existing vaccines like mRNA-1083, which already offers protection against multiple threats efficiently. This shift could hinder timely access to critical vaccines, including those needed for seasonal flu and COVID-19, while questioning the necessity of such strict requirements compared to current standards.